Zurich Cantonal Bank’s AbbVie ABBV Stock Holding History

Zurich Cantonal Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-666,741	Closed	-$152M	–	2550
2025 Q4	$152M	Buy	+666,741	New	+$152M	0.33%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Zurich Cantonal Bank's ABBV Position: Q2 2026 in Review

Zurich Cantonal Bank increased its AbbVie (ABBV) stake by 43% in Q2 2026, buying an estimated $61.2M and bringing the position to 945,063 shares worth $238M. The position accounts for 0.46% of the portfolio, ranked #31.

Zurich Cantonal Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Zurich Cantonal Bank held 945,063 shares of AbbVie worth $238M as of Q2 2026.
Zurich Cantonal Bank bought 284,487 AbbVie shares in Q2 2026, an estimated $61.2M.
AbbVie made up 0.46% of Zurich Cantonal Bank's portfolio in Q2 2026, its #31 holding.
Zurich Cantonal Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.